Eurofins Scientific Group Aktie [WKN: 910251 / ISIN: FR0000038259]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Eurofins Scientific Group S.A.

05.09.17		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 August 2017 (Businesswire)
01.08.17		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 July 2017 (Businesswire)
31.07.17		Eurofins Expands Its Offering and Footprint in Drug Discovery Services with the Acquisition of DiscoverX (Businesswire)
27.07.17		Eurofins Strengthens Its Non-Invasive Prenatal Testing Technology Portfolio with the Acquisition of a Majority Stake in LifeCodexx (Businesswire)
26.07.17		Eurofins Expands Its Leadership in Biopharmaceutical Services with the Acquisition of Advinus Therapeutics (Businesswire)
18.07.17		Eurofins Issues EUR 650m New Euro Bond (Businesswire)
17.07.17		Eurofins Announces the Potential Launch of a New Senior Eur 500m Bond on the Back of Strong M&A Activity (Businesswire)
10.07.17		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 June 2017 (Businesswire)
26.06.17		Eurofins Strengthens Its Specialty Clinical Diagnostics Footprint with the Acquisition of the Genoma Laboratory Group in Italy (Businesswire)
09.01.17		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 December 2016 (Businesswire)
01.12.16		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2016 (Businesswire)
03.11.16		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2016 (Businesswire)
20.10.16		Eurofins Scientific SE: Over 10% Organic Growth in the First Nine Months of 2016 (Businesswire)
06.10.16		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 September 2016 (Businesswire)
30.09.16		Eurofins Expands Its Clinical Diagnostic Footprint with the Acquisition of Megalab in Spain (Businesswire)
21.09.16		Eurofins Raises Its 2016 Profit Objectives and Sets Preliminary Eur 2.9bn Revenue Objective for 2017 (Businesswire)
15.09.16		Eurofins Expands Asia Pacific Capacity with a New State-of-the-Art Food Testing Laboratory in Singapore (Businesswire)
08.09.16		Eurofins raises EUR 296m following a successful equity issuance (Businesswire)
07.09.16		Eurofins Raises the Amount of New Shares Offered to 800,000 Driven by Strong Demand from Institutional Investors (Businesswire)
07.09.16		Eurofins announces the issuance of approximately 600,000 new shares to be placed via an accelerated book building offering to institutional investors (Businesswire)
01.09.16		Eurofins Expands Its Clinical Diagnostic Footprint with the Acquisition of VRL Laboratories in the USA (Businesswire)
02.08.16		Eurofins Scientific: Growth Momentum Sustained as Strong Q1 Operating Trends Continued in Q2 2016 (Businesswire)
26.07.16		Eurofins strengthens its footprint in food testing in New Zealand with the acquisition of Agfirst Bay of Plenty (Businesswire)
20.07.16		Eurofins Scientific SE: Viracor-IBT Laboratories Inc.’s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA (Businesswire)
05.07.16		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 June 2016 (Businesswire)
29.06.16		Eurofins Strengthens Its Growth Options With a EUR 200 Million Private Placement to La Caisse de dépôt et placement du Québec (Businesswire)
17.06.16		Eurofins Strengthens Its Footprint in Food and Water Testing in The Netherlands with the Acquisition of Bureau de Wit (Businesswire)
13.06.16		EUROFINS SCIENTIFIC Disclosure of Directors’ Dealings (Businesswire)
13.06.16		EUROFINS SCIENTIFIC Disclosure of directors’ dealings (Businesswire)
13.06.16		Eurofins Scientific Disclosure of Directors’ Dealings (Businesswire)
13.06.16		Eurofins Lancaster Laboratories Announces Major Expansion Plans to Enhance Its Laboratory Services Footprint and Create New Jobs in Ireland (Businesswire)
06.06.16		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 May 2016 (Businesswire)
01.06.16		Eurofins Reinforces Its Leading Footprint in Food Testing in France with the Acquisition of Agro-Analyses (Businesswire)
25.05.16		Eurofins Scientific SE - Notification of major holdings (Businesswire)
19.05.16		Eurofins Strengthens Its Footprint with the Acquisition of Exova’s Food, Water and Pharmaceutical Products Testing Laboratories in the UK & Ireland (Businesswire)
03.05.16		Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2016 (Businesswire)
02.05.16		Eurofins Reinforces Its Environment Testing Footprint with the Acquisition of EAC Corp. in Japan (Businesswire)
25.04.16		Eurofins Reinforces Its Specialty Clinical Diagnostics Footprint by Acquiring PerkinElmer’s NTD Laboratory Services Business (Businesswire)
25.04.16		Eurofins Achieves 48% Revenue Growth and over 10% Organic Growth in Q1 2016 (Businesswire)
31.03.16		Eurofins Reinforces Its Leadership in the Biopharmaceutical Products Testing Market with the Acquisition of Advantar Laboratories, Inc. (Businesswire)
18.03.16		Eurofins Scientific 2015 Annual Report Notification (Businesswire)
11.03.16		Eurofins Expands Its Leading Footprint in Biopharmaceutical Products Testing with the Acquisition of ams Laboratories in Australia (Businesswire)
01.03.16		Eurofins Genomics Opens State-of-the-Art Facility in Louisville, KY (Businesswire)
29.02.16		Outstanding 2015 Results above Recently Upgraded Objectives on All Metrics (Businesswire)
22.01.16		Eurofins Scientific: Biomnis, in Partnership with ODPM, Launches a Test to Determine the Toxicity Risk of Widely-Used Chemotherapy (Businesswire)
13.01.16		Eurofins reinforces its market leadership in pharmaceutical products testing with the acquisition of Sinensis Life Sciences B.V. (Businesswire)
07.01.16		Eurofins Genomics and Weatherbys Ireland Join Forces to Genotype One Million Cattle (Businesswire)
21.12.15		Eurofins Reinforces Market Leadership in Environment Testing in Europe with the Acquisition of NUA and Water & Waste Laboratories in Austria, and Radonlab in Norway (Businesswire)
10.12.15		Eurofins Decides Not to Proceed with the Placement Offer for New Shares Due to Poor Global Market Conditions (Businesswire)
09.12.15		Eurofins Announces the Launch of the Placement of Approximately 1 Million New Ordinary Shares by Way of an Accelerated Book Building Offering to Institutional Investors (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

DeepSeek sorgt nur noch partiell für anhaltenden Schock: SoftBank-Aktien & Co. auf Talfahrt - NVIDIA nach Rekordverlust erholt

Negative Entwicklungen am Krypto-Markt: Wieso Bitcoin, Ethereum, Ripple & Co. nachgeben

Ausblick EZB-Entscheid: Kommt es zu einer erneuten Zinssenkung?

ASML-Aktie weit im Plus: ASML übertrifft Erwartungen mit neuem Umsatzrekord

US-Notenbank Fed verzichtet auf Zinsschritt

NVIDIA-Aktie verliert: Weitere Exportbeschränkungen?

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	31.01.2025 22:16
Kaufwert:	EUR
	Hinzufügen Speichern